Add-on Acquisition • Life Science

Amdipharm Mercury Co. - AMCo. Acquires Abcur AB

On December 6, 2013, Amdipharm Mercury Co. - AMCo. acquired life science company Abcur AB

Acquisition Context
  • This is Amdipharm Mercury Co. - AMCo.’s 2nd transaction in the Life Science sector.
  • This is Amdipharm Mercury Co. - AMCo.’s 1st transaction in Sweden.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date December 6, 2013
Target Abcur AB
Sector Life Science
Buyer(s) Amdipharm Mercury Co. - AMCo.
Deal Type Add-on Acquisition

Target Company

Abcur AB

Sweden
Abcur AB is a Swedish based pharmaceutical company focusing on development, registration and marketing of specialized pharmaceutical products. Our strive is to make necessary pharmaceutical products available in the Nordic area. This is done by a close cooperation with the medical care.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Amdipharm Mercury Co. - AMCo.

Croydon, United Kingdom

Category Company
Sector Life Science
DESCRIPTION

Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.


Deal Context for Buyer #
Overall 2 of 3
Sector: Life Science 2 of 2
Type: Add-on Acquisition 2 of 3
Country: Sweden 1 of 1
Year: 2013 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-01 Focus Pharmaceuticals

London, United Kingdom

Focus Pharmaceuticals Ltd is a generic pharmaceutical company specializing in bringing new generic products to market in the UK.

Buy £50M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-14 Boucher & Muir Pty

Crows Nest, Australia

Boucher & Muir Pty Ltd. is a provider of medical products from vaccines to anaesthetics, as well as more typical products such as solid dose tablets and capsules.

Buy -